Rapid Micro Biosystems, Inc. (RPID) Misses Q3 EPS by 1c ; Offers Guidance

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $6.55 million.

GUIDANCE:

Rapid Micro Biosystems, Inc. sees FY2024 revenue of ~$27 million, versus the consensus of $26.6 million.

For earnings history and earnings-related data on Rapid Micro Biosystems, Inc. (RPID) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c